ClinicalTrials.Veeva

Menu
W

Women's and Children's Hospital | Haematology and Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3009104
Baricitinib
flucloxacillin
Sevoflurane
Irinotecan
AK0529
Dexmedetomidine
5'Azacitidine
cefalexin
Remifentanil

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 21 total trials
New

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY)

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to devel...

Begins enrollment in 2 months
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo
New

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes. Partici...

Begins enrollment in 4 months
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

A companion platform trial to test novel targeted agents based on the patient's tumor profile.

Enrolling
Recurrent Cancer
Childhood Solid Tumor
Drug: Paxalisib, Irinotecan, Temozolomide

Trial sponsors

M
Lilly logo
A
S
W
BioMarin Pharmaceutical logo
S
Shire logo
The University of Queensland logo
University of British Columbia logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems